A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Edap Tms Sa stock. As of the latest transaction made, Citadel Advisors LLC holds 44,500 shares of EDAP stock, worth $242,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,500
Previous 8,000 456.25%
Holding current value
$242,080
Previous $42,000 678.57%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.1 - $7.78 $67,437 - $102,874
13,223 Added 53.37%
38,000 $279,000
Q4 2023

Feb 14, 2024

SELL
$4.15 - $7.2 $107,829 - $187,077
-25,983 Reduced 51.19%
24,777 $130,000
Q3 2023

Nov 14, 2023

SELL
$6.2 - $9.34 $418,134 - $629,898
-67,441 Reduced 57.06%
50,760 $356,000
Q2 2023

Aug 14, 2023

BUY
$8.76 - $11.92 $542,252 - $737,859
61,901 Added 109.95%
118,201 $1.09 Million
Q1 2023

May 15, 2023

SELL
$10.44 - $12.49 $160,504 - $192,021
-15,374 Reduced 21.45%
56,300 $623,000
Q4 2022

Feb 14, 2023

SELL
$8.01 - $11.35 $642,658 - $910,633
-80,232 Reduced 52.82%
71,674 $764,000
Q3 2022

Nov 14, 2022

BUY
$6.25 - $8.94 $763,800 - $1.09 Million
122,208 Added 411.5%
151,906 $1.25 Million
Q2 2022

Aug 15, 2022

BUY
$6.24 - $7.44 $18,021 - $21,486
2,888 Added 10.77%
29,698 $202,000
Q4 2021

Feb 14, 2022

BUY
$5.3 - $6.3 $53,630 - $63,749
10,119 Added 60.63%
26,810 $0
Q2 2021

Aug 16, 2021

BUY
$5.88 - $9.54 $1,999 - $3,243
340 Added 2.08%
16,691 $0
Q4 2020

Feb 16, 2021

BUY
$3.91 - $5.25 $63,932 - $85,842
16,351 New
16,351 $85,000
Q2 2019

Aug 14, 2019

SELL
$2.58 - $5.31 $26,318 - $54,167
-10,201 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$1.87 - $3.14 $8,822 - $14,814
-4,718 Reduced 31.62%
10,201 $0
Q1 2018

May 11, 2018

BUY
$2.2 - $2.86 $3,575 - $4,647
1,625 Added 12.22%
14,919 $34,000
Q4 2017

Feb 09, 2018

BUY
$2.65 - $3.39 $35,229 - $45,066
13,294
13,294 $38,000

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $197M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.